Your browser doesn't support javascript.
loading
Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma.
Hsu, P-K; Chen, H-S; Huang, C-S; Liu, C-C; Hsieh, C-C; Hsu, H-S; Wu, Y-C; Wu, S-C.
Afiliação
  • Hsu PK; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chen HS; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Huang CS; Institute of Health and Welfare Policy, National Yang-Ming University, Taipei, Taiwan.
  • Liu CC; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Hsieh CC; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Hsu HS; Division of Thoracic Surgery, Department of Surgery, Koo Foundation Sun Yat-Sen Cancer Centre, Taipei, Taiwan.
  • Wu YC; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Wu SC; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Br J Surg ; 104(1): 90-97, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27859017
ABSTRACT

BACKGROUND:

Patterns of recurrence after surgery with postoperative chemoradiotherapy (S-CCRT) or surgery alone in patients with oesophageal squamous cell carcinoma (SCC) may differ. This might influence the nature and timing of subsequent management strategies.

METHODS:

Patients with SCC who had undergone R0 resection were included. Propensity score matching was used to select matched groups. Survival and recurrence were compared by Kaplan-Meier analysis. Univariable and multivariable Cox regression analyses were used to identify prognostic factors for overall and disease-free survival.

RESULTS:

A total of 1390 patients were included, of whom 1000 had surgery alone and 390 underwent S-CCRT. Propensity score matching yielded 213 well balanced pairs. The 3-year overall survival rate and median survival time in the S-CCRT group were 0·50 and 36·5 (95 per cent c.i. 25·1 to 52·6) months respectively, compared with 0·38 and 22·8 (18·2 to 29·0) months in the surgery-alone group (P = 0·006). The 3-year disease-free survival rate and median disease-free survival time in the S-CCRT group were 0·46 and 30·6 (22·2 to 39·3) months respectively, compared with 0·36 and 17·6 (11·3 to 23·9) months in the surgery-alone group (P = 0·006). The 2-year freedom from locoregional recurrence rate was 0·87 and 0·77 in the S-CCRT and surgery-alone groups respectively (P = 0·003). In multivariable analysis, independent prognostic factors for disease-free survival included age over 56 years, pT3-4 category, pN category, poor differentiation, tumour length exceeding 4·0 cm, and receiving postoperative chemoradiotherapy (hazard ratio 0·62, 95 per cent c.i. 0·47 to 0·81; P < 0·001).

CONCLUSION:

Oesophagectomy with postoperative chemoradiotherapy was associated with longer survival and lower recurrence rates, especially at a locoregional level, compared with surgery alone.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Esofagectomia / Quimiorradioterapia Adjuvante / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Br J Surg Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Esofagectomia / Quimiorradioterapia Adjuvante / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Br J Surg Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Taiwan